BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 23618908)

  • 1. Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage.
    Ozaki T; Wu D; Sugimoto H; Nagase H; Nakagawara A
    Cell Death Dis; 2013 Apr; 4(4):e610. PubMed ID: 23618908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity.
    Ozaki T; Sugimoto H; Nakamura M; Hiraoka K; Yoda H; Sang M; Fujiwara K; Nagase H
    FEBS J; 2015 Jan; 282(1):114-28. PubMed ID: 25331851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Runt-related transcription factor 1 (RUNX1) stimulates tumor suppressor p53 protein in response to DNA damage through complex formation and acetylation.
    Wu D; Ozaki T; Yoshihara Y; Kubo N; Nakagawara A
    J Biol Chem; 2013 Jan; 288(2):1353-64. PubMed ID: 23148227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms.
    Manzotti G; Torricelli F; Donati B; Sancisi V; Gugnoni M; Ciarrocchi A
    J Exp Clin Cancer Res; 2019 Aug; 38(1):346. PubMed ID: 31395086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase 2 is involved in DNA damage-mediated cell death of human osteosarcoma cells through stimulation of the ATM/p53 pathway.
    Sun D; Yu M; Li Y; Xing H; Gao Y; Huang Z; Hao W; Lu K; Kong C; Shimozato O; Ozaki T; Zhu Y
    FEBS Open Bio; 2019 Mar; 9(3):478-489. PubMed ID: 30868056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.
    van der Deen M; Taipaleenmäki H; Zhang Y; Teplyuk NM; Gupta A; Cinghu S; Shogren K; Maran A; Yaszemski MJ; Ling L; Cool SM; Leong DT; Dierkes C; Zustin J; Salto-Tellez M; Ito Y; Bae SC; Zielenska M; Squire JA; Lian JB; Stein JL; Zambetti GP; Jones SN; Galindo M; Hesse E; Stein GS; van Wijnen AJ
    J Biol Chem; 2013 Jul; 288(29):21307-21319. PubMed ID: 23720736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory role of E2F-1 in the regulation of tumor suppressor p53 during DNA damage response.
    Yoshihara Y; Wu D; Kubo N; Sang M; Nakagawara A; Ozaki T
    Biochem Biophys Res Commun; 2012 Apr; 421(1):57-63. PubMed ID: 22480684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter.
    Westendorf JJ; Zaidi SK; Cascino JE; Kahler R; van Wijnen AJ; Lian JB; Yoshida M; Stein GS; Li X
    Mol Cell Biol; 2002 Nov; 22(22):7982-92. PubMed ID: 12391164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of type I Runx2 mediated by dexamethasone is required for 3T3-L1 adipogenesis.
    Zhang YY; Li X; Qian SW; Guo L; Huang HY; He Q; Liu Y; Ma CG; Tang QQ
    Mol Endocrinol; 2012 May; 26(5):798-808. PubMed ID: 22422618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A newly identified dependence receptor UNC5H4 is induced during DNA damage-mediated apoptosis and transcriptional target of tumor suppressor p53.
    Wang H; Ozaki T; Shamim Hossain M; Nakamura Y; Kamijo T; Xue X; Nakagawara A
    Biochem Biophys Res Commun; 2008 Jun; 370(4):594-8. PubMed ID: 18402767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents.
    Namdar M; Perez G; Ngo L; Marks PA
    Proc Natl Acad Sci U S A; 2010 Nov; 107(46):20003-8. PubMed ID: 21037108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARID1A-mutated ovarian cancers depend on HDAC6 activity.
    Bitler BG; Wu S; Park PH; Hai Y; Aird KM; Wang Y; Zhai Y; Kossenkov AV; Vara-Ailor A; Rauscher FJ; Zou W; Speicher DW; Huntsman DG; Conejo-Garcia JR; Cho KR; Christianson DW; Zhang R
    Nat Cell Biol; 2017 Aug; 19(8):962-973. PubMed ID: 28737768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
    Feng R; Dong L
    Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F1 regulates p53R2 gene expression in p53-deficient cells.
    Qi JJ; Liu L; Cao JX; An GS; Li SY; Li G; Jia HT; Ni JH
    Mol Cell Biochem; 2015 Jan; 399(1-2):179-88. PubMed ID: 25312903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
    Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
    Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner.
    Jensen ED; Schroeder TM; Bailey J; Gopalakrishnan R; Westendorf JJ
    J Bone Miner Res; 2008 Mar; 23(3):361-72. PubMed ID: 17997710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RUNX3 modulates DNA damage-mediated phosphorylation of tumor suppressor p53 at Ser-15 and acts as a co-activator for p53.
    Yamada C; Ozaki T; Ando K; Suenaga Y; Inoue K; Ito Y; Okoshi R; Kageyama H; Kimura H; Miyazaki M; Nakagawara A
    J Biol Chem; 2010 May; 285(22):16693-703. PubMed ID: 20353948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Runx2- and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression.
    Lamour V; Detry C; Sanchez C; Henrotin Y; Castronovo V; Bellahcène A
    J Biol Chem; 2007 Dec; 282(50):36240-9. PubMed ID: 17956871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIPK2 modulates p53 activity towards pro-apoptotic transcription.
    Puca R; Nardinocchi L; Sacchi A; Rechavi G; Givol D; D'Orazi G
    Mol Cancer; 2009 Oct; 8():85. PubMed ID: 19828042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells.
    Estève PO; Chin HG; Pradhan S
    J Biol Chem; 2007 Jan; 282(4):2615-25. PubMed ID: 17124180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.